BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 25217799)

  • 1. Detection of circulating tumor cells in patients with breast cancer using the quantitative RT-PCR assay for monitoring of therapy efficacy.
    Wang HY; Ahn S; Kim S; Park S; Park S; Han H; Sohn JH; Kim S; Lee H
    Exp Mol Pathol; 2014 Dec; 97(3):445-52. PubMed ID: 25217799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor cells in patients with breast cancer: monitoring chemotherapy success.
    Ušiaková Z; Mikulová V; Pintérová D; Brychta M; Valchář J; Kubecová M; Tesařová P; Bobek V; Kološtová K
    In Vivo; 2014; 28(4):605-14. PubMed ID: 24982230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection.
    Pinzani P; Salvadori B; Simi L; Bianchi S; Distante V; Cataliotti L; Pazzagli M; Orlando C
    Hum Pathol; 2006 Jun; 37(6):711-8. PubMed ID: 16733212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of circulating tumor cell-specific markers in breast cancer patients using the quantitative RT-PCR assay.
    Wang HY; Ahn S; Kim S; Park S; Jung D; Park S; Han H; Sohn J; Kim S; Lee H
    Int J Clin Oncol; 2015 Oct; 20(5):878-90. PubMed ID: 25708591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of circulating tumor cells during follow-up of patients with early breast cancer: Clinical utility for monitoring of therapy efficacy.
    Mikulová V; Cabiňaková M; Janatková I; Mestek O; Zima T; Tesařová P
    Scand J Clin Lab Invest; 2014 Mar; 74(2):132-42. PubMed ID: 24350991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of circulating tumor cells in breast cancer patients using multiplex reverse transcription-polymerase chain reaction and specific primers for MGB, PTHRP and KRT19 correlation with clinicopathological features.
    Skondra M; Gkioka E; Kostakis ID; Pissimissis N; Lembessis P; Pectasides D; Koutsilieris M
    Anticancer Res; 2014 Nov; 34(11):6691-9. PubMed ID: 25368276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time quantitative RT-PCR detection of circulating tumor cells from breast cancer patients.
    Guo M; Li X; Zhang S; Song H; Zhang W; Shang X; Zheng Y; Jiang H; Lv Q; Jiang Y; Hao H
    Int J Oncol; 2015 Jan; 46(1):281-9. PubMed ID: 25353649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokeratin 19-positive circulating tumor cells in early breast cancer prognosis.
    Saloustros E; Mavroudis D
    Future Oncol; 2010 Feb; 6(2):209-19. PubMed ID: 20146580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of circulating tumor cells in peripheral blood of heavily treated metastatic breast cancer patients.
    Tokudome N; Ito Y; Takahashi S; Kobayashi K; Taira S; Tsutsumi C; Oto M; Oba M; Inoue K; Kuwayama A; Masumura K; Nakayama Y; Watanabe C; Hatake K
    Breast Cancer; 2011 Jul; 18(3):195-202. PubMed ID: 21465230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Circulating Tumor Cells in Breast Cancer Patients Using Cytokeratin-19 Real-Time RT-PCR.
    Park HS; Han HJ; Lee S; Kim GM; Park S; Choi YA; Lee JD; Kim GM; Sohn J; Kim SI
    Yonsei Med J; 2017 Jan; 58(1):19-26. PubMed ID: 27873491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
    Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
    Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.
    Apostolaki S; Perraki M; Kallergi G; Kafousi M; Papadopoulos S; Kotsakis A; Pallis A; Xenidis N; Kalmanti L; Kalbakis K; Agelaki S; Kalykaki A; Stournaras C; Stathopoulos E; Georgoulias V; Mavroudis D
    Breast Cancer Res Treat; 2009 Oct; 117(3):525-34. PubMed ID: 19016323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer.
    Divella R; Daniele A; Savino E; Palma F; Bellizzi A; Giotta F; Simone G; Lioce M; Quaranta M; Paradiso A; Mazzocca A
    Anticancer Res; 2013 Apr; 33(4):1491-7. PubMed ID: 23564790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR in breast cancer: a meta-analysis of published literature.
    Zhao S; Liu Y; Zhang Q; Li H; Zhang M; Ma W; Zhao W; Wang J; Yang M
    Breast Cancer Res Treat; 2011 Dec; 130(3):809-16. PubMed ID: 21311967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
    Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
    Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients.
    Kim SJ; Masago A; Tamaki Y; Akazawa K; Tsukamoto F; Sato J; Ozawa T; Tsujino Y; Noguchi S
    Breast Cancer Res Treat; 2011 Aug; 128(3):765-73. PubMed ID: 21630023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of front-line chemotherapy on circulating CK-19 mRNA-positive cells in patients with metastatic breast cancer.
    Georgoulias V; Apostolaki S; Bozionelou V; Politaki E; Perraki M; Georgoulia N; Kalbakis K; Kotsakis A; Xyrafas A; Agelaki S; Mavroudis D
    Cancer Chemother Pharmacol; 2014 Dec; 74(6):1217-25. PubMed ID: 25344760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTCs in primary breast cancer (II).
    Saloustros E; Mavroudis D
    Recent Results Cancer Res; 2012; 195():187-92. PubMed ID: 22527506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.
    Xenidis N; Ignatiadis M; Apostolaki S; Perraki M; Kalbakis K; Agelaki S; Stathopoulos EN; Chlouverakis G; Lianidou E; Kakolyris S; Georgoulias V; Mavroudis D
    J Clin Oncol; 2009 May; 27(13):2177-84. PubMed ID: 19332733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble VCAM-1 and E-selectin in breast cancer: relationship with staging and with the detection of circulating cancer cells.
    Silva HC; Garcao F; Coutinho EC; De Oliveira CF; Regateiro FJ
    Neoplasma; 2006; 53(6):538-43. PubMed ID: 17167725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.